oxyphenbutazone has been researched along with Blood Coagulation Disorders in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubinstein, A | 1 |
| Beck, EA | 1 |
| Lerber, W | 1 |
| Torriani, R | 1 |
| Hobbs, CB | 1 |
| Miller, AL | 1 |
| Thornley, JH | 1 |
2 other studies available for oxyphenbutazone and Blood Coagulation Disorders
| Article | Year |
|---|---|
[Congenital factor 13 deficiency: severe abdominal hemorrhage after combined antiinflammatory therapy].
Topics: Appendectomy; Appendicitis; Aspirin; Blood Coagulation Disorders; Blood Platelets; Blood Transfusion | 1971 |
Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).
Topics: Blood Coagulation Disorders; Hemorrhage; Humans; Middle Aged; Oxyphenbutazone; Warfarin | 1965 |